BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Drug Development

  Celgene International Sárl Release: Phase III Study Evaluating REVLIMID® in Patients with High-Risk Smoldering Multiple Myeloma Presented at American Society of Hematology

  December 14, 2011

   · 

  1 min read
• Drug Development

  Threshold Pharmaceuticals, Inc. Announces Promising Phase 1 Clinical Trial Results in Patients With Advanced Leukemias

  December 14, 2011

   · 

  5 min read
• Business

  Simcere Pharmaceutical Group and Bristol-Myers Squibb Company Enter Innovative Partnership to Develop Cardiovascular Compound

  December 14, 2011

   · 

  1 min read
• Deals

  Greatbatch, Inc. Scoops Up Micro Power Electronics for $60 Million Cash

  December 14, 2011

   · 

  4 min read
• FDA

  FDA Approves Dako A/S HER2 CISH pharmDx(TM) Kit

  December 14, 2011

   · 

  4 min read
• FDA

  Doctor’s Medical Device Gets Quick FDA Approval

  December 14, 2011

   · 

  1 min read
• BioCapital

  FDA Issues Warning Letters for Misleading Advertising of Allergan Inc.'s Lap-Band

  December 14, 2011

   · 

  4 min read
• Business

  The Best Biotech CEO of 2011 Is...

  December 14, 2011

   · 

  1 min read
• Pharm Country

  Merck & Co., Inc. CEO Defends R&D Strategy

  December 14, 2011

   · 

  1 min read
• Genetown

  CEO Says Genzyme Corporation Ready to Roll, Remains Committed to Massachusetts

  December 14, 2011

   · 

  1 min read